based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for GPT Healthcare Ltd. An average target of ₹255
Source: S&P Global Market Intelligence
GPT Healthcare Ltd price forecast by 1 analysts
Upside of57.78%
High
₹255
Target
₹255.00
Low
₹255
GPT Healthcare Ltd target price ₹255, a slight upside of 57.78% compared to current price of ₹166.93. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
GPT Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2026:0
Forecast
Actual
Including amortisation and stock based compensations
GPT Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2026:0
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -3.66 % |
3 Month Return | -17.8 % |
1 Year Return | -19.47 % |
Market Stats | |
Previous Close | ₹161.62 |
Open | ₹161.25 |
Volume | 1.42L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,326.17Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹1,326.17 Cr |
P/B Ratio | 6.63 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 24.89 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹1,326.17 Cr | -3.89% | 0.59 | ₹41 Cr | ₹337 Cr | |
BUY | ₹25,790.33 Cr | 64.12% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
NA | ₹80.50 Cr | 34.74% | 0.56 | -₹2 Cr | ₹39 Cr | |
NA | ₹39.83 Cr | 32.5% | 1.33 | ₹2 Cr | ₹10 Cr | |
NA | ₹3,806.60 Cr | 174.5% | 0.56 | NA | NA |
Organisation | GPT Healthcare Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for GPT Healthcare Ltd
GPT Healthcare is listed among companies that have experienced significant declines, falling 12-40% from their listing day close price within a month.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 15.96% to 17.73% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 65.57% of holdings in Sep 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 5.38% to 4.70% in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 8.52% to 7.43% in Sep 2024 quarter
Price Dip
In the last 3 months, GPTHEALTH stock has moved down by -17.8%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 65.57% | 0.00 | |
Foreign Institutions | 4.7% | ||
Mutual Funds | 7.43% | ||
Retail Investors | 17.73% | 11.07 | |
Others | 4.57% | 0.11 |
GPT Healthcare Ltd’s net profit jumped 9.78% since last year same period to ₹14.82Cr in the Q2 2024-2025. On a quarterly growth basis, GPT Healthcare Ltd has generated 48.8% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, GPT Healthcare Ltd has declared dividend of ₹1.50 - translating a dividend yield of 1.55%.
Read More about DividendsBearish
Neutral
Bullish
GPT Healthcare Ltd is currently in a Bearish trading position according to technical analysis indicators.
GPT Healthcare Ltd (GPTHEALTH) share price today is ₹166.93
GPT Healthcare Ltd is listed on NSE
GPT Healthcare Ltd is listed on BSE
Today’s traded volume of GPT Healthcare Ltd(GPTHEALTH) is 1.42L.
Today’s market capitalisation of GPT Healthcare Ltd(GPTHEALTH) is ₹1326.17Cr.
GPT Healthcare Ltd(GPTHEALTH | Price |
---|---|
52 Week High | ₹219.9 |
52 Week Low | ₹128.7 |
GPT Healthcare Ltd(GPTHEALTH) share price is ₹166.93. It is down -24.09% from its 52 Week High price of ₹219.9
GPT Healthcare Ltd(GPTHEALTH) share price is ₹166.93. It is up 29.70% from its 52 Week Low price of ₹128.7
GPT Healthcare Ltd(GPTHEALTH | Returns |
---|---|
1 Day Returns | 5.31% |
1 Month Returns | -3.66% |
3 Month Returns | -17.8% |
1 Year Returns | -19.47% |